Evidence map›Paper›PMID 41705870›Full record

ArticleReproduction & fertility2026

The value of a non-invasive bladder sensitivity paradigm in chronic pelvic pain.

Lydia Coxon, Emily Tan, Michal Krassowski, Pedro Abreu Mendes, Joana Ferreira Gomes, Claire E Lunde, Jane Meijlink, Danielle Perro, Lars Arendt-Nielsen, Qasim Aziz and 18 more

Abstract read
In one paragraph

Article in Reproduction & fertility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Lydia CoxonUniversity of Oxford, Oxford, UK.ORCID 0000-0003-0818-1240
Emily TanUniversity of Oxford, Oxford, UK.
Michal KrassowskiUniversity of Oxford, Oxford, UK.
Pedro Abreu MendesIBMC and Faculty of Medicine of University of Porto, Porto, Portugal.
Joana Ferreira GomesIBMC and Faculty of Medicine of University of Porto, Porto, Portugal.
Claire E LundeUniversity of Oxford, Oxford, UK.
Jane MeijlinkInternational Painful Bladder Foundation, Naarden, The Netherlands.
Danielle PerroUniversity of Oxford, Oxford, UK.
Lars Arendt-NielsenAalborg University, Aalborg, Denmark.
Qasim AzizWingate Institute of Neurogastroenterology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Christian M BeckerUniversity of Oxford, Oxford, UK.
Judy BirchPelvic Pain Support Network, Poole, United Kingdom.
Ana CharruaIBMC and Faculty of Medicine of University of Porto, Porto, Portugal.
Lysia DemetriouUniversity of Oxford, Oxford, UK.ORCID 0000-0001-5249-0900
Emma EvansUniversity of Oxford, Oxford, UK.
Anja HoffmanBayer AG, Research & Development, Pharmaceuticals, Berlin, Germany.
Andrew W HorneCentre for Reproductive Health, Institute of Regeneration and Repair, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-9656-493X
Lone HummelshojEndometriosis.org, London, United Kingdom.
Stacey A MissmerMichigan State University, East Lansing, Michigan, USA.
Eloise PassarellaUniversity of Oxford, Oxford, UK.
Esther Pogatzki-ZahnUniversity Hospital Muenster, Muenster, Germany.
Rolf-Detlef TreedeHeidelberg University, Mannheim, Germany.
Jan VollertDepartment of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
Krina T ZondervanUniversity of Oxford, Oxford, UK.
Christine B SiebergBoston's Children's Hospital, Boston, USA.
Francisco CruzIBMC and Faculty of Medicine of University of Porto, Porto, Portugal.
Jens NagelExploratory Pathobiology, Research & Development, Pharmaceuticals, Bayer Aktiengesellschaft, Wuppertal, Germany.
Katy VincentUniversity of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abstract: We explore bladder sensitivity profiles in females with chronic pelvic pain, using a non-invasive bladder sensitivity paradigm. We aim to determine how profiles differ between groups defined by symptoms; groups defined by diagnoses; and understanding how bladder sensitivity relates to clinical symptoms. A previously developed non-invasive bladder sensitivity paradigm will be used, which assesses pain and urgency ratings during physiological bladder filling, time to reach descriptive sensations, and volume voided at the paradigm end. Our cohort comprised individuals with (pain + bladder) and without (pain only) overt bladder symptoms and pain-free/bladder-symptom-free controls; within both pain groups were participants with and without endometriosis. In addition, questionnaires were completed, which included bladder- and bowel-related symptoms. Participants with pain + bladder symptoms had significantly greater pain intensity scores throughout the paradigm compared with controls. When looking at underlying diagnoses, the only significant difference between those with bladder symptoms, with and without endometriosis, was in the volume voided at the end of the paradigm. We found correlations between pain ratings during the paradigm and gastrointestinal symptom scores from questionnaires. We found that the paradigm can distinguish between those with overt bladder symptoms and controls. It also appears to potentially identify a group of individuals with 'silent' bladder symptoms. It is currently unclear whether those with 'silent' symptoms go on to develop overt symptoms. Overall, our study highlights the need to explore bladder sensitivity in individuals with any form of chronic pelvic pain, as comorbidity is common and 'silent' symptoms are not well understood. Lay summary: This study explored bladder sensitivity in people with chronic pelvic pain, with and without bladder symptoms, compared with a control group of people without pain. We wanted to explore pain and urgency when people drank water and how this differed in people with different symptoms and diagnoses. We asked people to drink 20 fl oz of water and give ratings of pain and urgency throughout, as well as when they felt certain sensations. We found differences between those with overt bladder symptoms and the control group, with those with overt bladder symptoms experiencing greater pain. We did not find differences between different diagnoses (e.g. those with and without endometriosis) in pain or urgency ratings. This study highlights the need to explore bladder sensitivity in individuals with any form of chronic pelvic pain.

Indexed as

Chronic PainPelvic PainUrinary BladderAdultEndometriosisFemaleHumansMiddle AgedPain MeasurementPain ThresholdSurveys and Questionnairesbladder painchronic pelvic painendometriosisIC/BPSvisceral sensitivity

Identifiers

PMID41705870
PMCPMC12974766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.